Venture-backed AbCellera closes Nasdaq IPO, raises $555m

AbCellera, a Vancouver, British Columbia-based developer of therapeutic antibodies, has closed its IPO on the NASDAQ at a price of US$20 per share, including the greenshoe option.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this